AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Evogene Ltd.
Video analysis: EVGN
All videosNo video analysis for this stock yet. Request one from our team.
News: EVGN
EverGen to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto
Vancouver, British Columbia--(Newsfile Corp. - September 14, 2026) - EverGen Infrastructure Corp. (TSXV: EVGN) (OTCQB: EVGIF) is pleased to announce its participation in the upcoming 3 rd Annual ArcStone-Kingswood Growth Summit in Toronto, taking place on September 16, 2026, at the Sheraton Center Toronto Hotel. Chase Edgelow, Co-founder & Chief Executive Office of EverGen, will participate as a Featured Company and will hold one-on-one meetings with interested investors and capital markets professionals.
Evogene Ltd. (NASDAQ:EVGN) Short Interest Down 77.2% in August
Evogene Ltd. (NASDAQ: EVGN - Get Free Report) was the target of a large drop in short interest in August. As of August 31st, there was short interest totaling 53,001 shares, a drop of 77.2% from the August 15th total of 232,078 shares. Based on an average daily volume of 219,870 shares, the short-interest ratio is
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward
Company urges shareholders to evaluate the significant changes already implemented and vote FOR all Evogene nominees on September 4, 2026, Annual General Meeting REHOVOT, Israel, Aug. 31, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneer in computational chemistry specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, today responded to the latest communication from dissident shareholders L.I.A.
EverGen Infrastructure Corp. (EVGN:CA) Q2 2026 Earnings Call Transcript
EverGen Infrastructure Corp. (EVGN:CA) Q2 2026 Earnings Call Transcript
EverGen Infrastructure Reports Q2 2026 Results
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQB: EVGIF), today reported financial results as at and for Q2 2026. All amounts are in Canadian dollars and are presented in thousands of dollars unless otherwise stated and have been prepared in accordance with IFRS. Financial Highlights The following table presents EverGen's Consolidated Financial and Operating Summary: Three months ended June 30, 2026 June 30, 2025 $ C.
EverGen Infrastructure Announces Voting Results for the Annual General Meeting of Shareholders Held on August 25, 2026
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN), is pleased to report the voting results from its Annual General Meeting of Shareholders (“AGM”) held on August 25, 2026. A total of 16,172,472 common shares were represented at the meeting, representing 62.43% of the Company's outstanding shares. The following is a summary of the proxy voting results for the AGM. 1. Election of Directors The following individuals were elected as.
EverGen Infrastructure Corp. (EVGN:CA) Shareholder/Analyst Call Prepared Remarks Transcript
EverGen Infrastructure Corp. (EVGN:CA) Shareholder/Analyst Call Prepared Remarks Transcript
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees
Recommendations Reinforce Confidence in Evogene's Strategic Plan and Long-Term Value Creation Strategy Board Urges Shareholders to Vote FOR All Evogene Nominees, and to disregard the Pure Capital Nominees, at the September 4, 2026, Annual General Meeting REHOVOT, Israel, Aug. 25, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, today announced that leading independent proxy advisory firms Institutional Shareholder Services ("ISS") and Glass Lewis have recommended that Evogene shareholders vote "FOR" the Company slate of nominees in connection with the September 4, 2026 Annual General Meeting of Shareholders.
